In 2012, drugs worth $35 billion went off-patent in the US, while the market size of drugs which will see patent expiry in 2013 will halve to $17 billion.
Past two years have witnessed a churn, mainly in the area of mergers and acquisitions.
The plan is to issue CLs for Trastuzumab (or Herceptin, used for treating breast cancer), Ixabepilone (used for chemotherapy in breast cancer treatment) and Dasatinib (or Sprycel, for leukaemia).
Sets up new financial services arm, Amit Goenka joins as CEO.
Golden Eagle was first launched 12 years ago, but the Ghaziabad-headquartered company stopped marketing the product a few years ago, to focus totally on its alcoholic division.
Bharti Infratel plans to raise Rs 4,500 cr through its IPO.
We believe a global PE firm with a dedicated clean resources fund can bring new ideas, as well as technologies, to Indian firms, say Sunil Ghorawat.
According to sources, Piramal has plans to sell part of Gulita, his sea-facing property in Worli, Mumbai, for Rs 450-500 crore (Rs 4.5-5 billion).
Air India Express currently operates 145 daily flights, down from about 200 six months ago.
The move comes amid expectations that the government would allow foreign airlines to invest directly in Indian carriers.
Several PE managers now prefer Sanskrit names for their funds over typical foreign names
Early this week, Sebi notified AIF regulations for private equity, hedge funds, venture capital funds and real estate funds, among others.
Real estate major Parsvnath Developers may soon be able to reduce a significant chunk of its debt, thanks to certain corporate giants showing interest in buying a prime piece of property it owns in the national capital.
The poster boys of Indian private equity are getting a reality check. If last year many of them branched out independently with their entrepreneurial PE shops, many are scaling down or biting the dust a year down the line.
Automotive designer Dilip Chhabria is planning to raise about Rs 100 crore to fund a new super-luxury car project for DC Design that he promotes, banking sources said on Tuesday.
PE firm goes in for image makeover, appoints advisory group.
Indian pharmaceutical companies, which always wanted a big share in the global copycat drug market, are betting high on the oral contraceptive (OC) market in America.
Its first and only investment in India out of its Asia-dedicated fund has gone bad.
Hilton's inspiring personal memoir seems to have inspired sons of India's top corporate honchos. Only they are not following in their fathers' footsteps to make their presence felt.
Tapping opportunities in this growing industry, major players are expanding their business and raising funds through the public market or private equity route.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances